A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
about
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancerHost microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactionsExpression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stressBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsThe CXCL8-CXCR1/2 pathways in cancerTargeting CXCR1/CXCR2 receptor antagonism in malignant melanomaIL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIARInteraction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invaInduction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cellsTissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cellsPI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cellsCXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesisTransactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.Interleukin-8 in breast cancer progression.Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 productionDefining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cellsAn integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells.Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionIL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cellsSerial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior.Gastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression.IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.Sex steroid regulation of angiogenesis in breast tissue.Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.Chemokines: novel targets for breast cancer metastasisCancer cell angiogenic capability is regulated by 3D culture and integrin engagementInflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast texturesSohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
P2860
Q24684115-190BDA56-EE8D-4A10-942F-3A7C5848C14AQ24795087-D37A1F42-A2F9-4491-800C-1967EDBB7BE8Q24797535-1F28CC76-85F3-4299-A3FE-7DC1E1A331C8Q26766205-AD3F64D7-6494-40DC-982A-2FFAB026F2BBQ28075994-F898C554-E180-4F83-911B-84C153616F5CQ28276026-F985B038-FD8E-47DC-9F1F-A7FFEEFDF813Q28290549-1530BF74-7A27-4C06-89AD-3F31624ECDFBQ28394879-FF7509B2-5E8C-4C2A-8005-EE3990D7AC37Q30353532-366A2B09-273E-421A-B76D-C0DDE3A5B3FEQ33587770-B70E7448-85AE-4978-9D1A-C4EAB2984C90Q33714244-A40106B5-32BF-4D7F-9751-147118F5027DQ33723243-F0C925ED-539F-404E-B51D-C061C7287F92Q33751266-9BEB2C74-9D2D-4A77-8A7D-D64D0E790122Q33808945-A5EBB4BF-0BB7-453A-9F09-0D9DD99DEA16Q33945648-4C34DC6E-5C15-4C1B-9B6E-A60F4C660904Q34095143-DE04E9FD-7722-4E63-8658-8995AFA3326EQ34249533-E1237EE9-1C3B-403B-9B09-31218DD5AB44Q34346108-A755E7A4-114B-4A45-9F50-D0B97714A832Q34367591-8458ECEE-B186-428E-8FED-9EB12C14149FQ34379330-8D97BCD2-BDB7-4FEC-AC7E-840969F33EF0Q34438000-6BA2FB90-31DD-47DD-9361-35309405B576Q34474210-C9A081D3-6845-4B43-BA58-D25BC5431822Q34706426-0C57CFA9-0424-4C6F-AB42-EE22940E2D94Q34984217-EAEEFD19-FF70-4AAD-A804-CFBCA6BCE7D8Q35141573-AF149960-F8E3-4891-A7C0-C22AEFDF76E0Q35325472-3D3DEA02-EFA3-42A2-AF1C-36358D004ABEQ35659991-0CB00E1F-8BF5-404F-9297-088488EBF750Q35686250-4F3F9CDF-DB54-40E3-903F-A02CA1ED87FCQ35838937-26F03AE3-69BE-4708-8495-53ACAB821853Q36029627-50BE4B92-B377-4E2B-A8EF-775740711E3DQ36067344-57ADF675-A018-4C74-8F1C-8C195977755CQ36082753-FF944A14-FA9B-45E1-8BFB-B0DCFE3B7084Q36279901-191FE033-E664-4C94-B4A9-81996D0AFC40Q36292019-F69C6FA7-B25C-4635-8642-A961FF83CF84Q36355925-351B5CB7-3AAB-4C8F-BAA5-345C6E7F1B79Q36843035-878D4D22-1957-4FCA-8A1C-931FAAD843A7Q36918688-8F276E1C-129A-4559-A1E5-32A2A3AF6B0CQ37061984-2E80D59B-446E-49B8-B5F1-8E4336EAD989Q37448056-8C7209CC-933D-4490-BC15-0D3BB944E387Q37580242-DCCB36A9-D18E-46B9-BEDB-B5622E10D2FB
P2860
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@ast
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@en
type
label
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@ast
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@en
prefLabel
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@ast
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@en
P2093
P2860
P1476
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.
@en
P2093
B R Wuertz
D E Gamache
J C Manivel
J E De Larco
K A Rosner
L T Furcht
S A Erickson
P2860
P304
P356
10.1016/S0002-9440(10)64005-9
P407
P577
2001-02-01T00:00:00Z